Novonesis is a global biosolutions leader formed through the merger of Novozymes and Chr. Hansen, combining deep expertise in enzymes, probiotics, and microbial technologies to serve over 30 industries across food, health, agriculture, and sustainable manufacturing.
Headquartered in Denmark with around 10,000 employees worldwide, Novonesis operates across three key division, Biosolutions for Food & Beverages, which help improve taste, texture, shelf life, nutrition, and sustainability in everyday foods, Biosolutions for Human Health, offering clinically tested probiotics, enzymes, and novel nutrients to support lifelong well-being and Biosolutions for Planetary Health, which drive environmental efficiency by reducing energy, water, and chemical use across agriculture and industry.
Guided by the purpose “There’s a biosolution for (almost) everything,” Novonesis exists to address the world’s most pressing challenges from feeding a growing population to improving health and safeguarding the planet—through the power of nature and science.
